Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,289 public trials 414 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Completed

Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma

NCT03473756

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UChicago Medicine Comprehensive Cancer Center - Hyde Park Chicago, Illinois, United States
  • Barbara Ann Karmanos Cancer Institute - Detroit Headquarters Detroit, Michigan, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View all 30 locations
View Trial Details
Completed

Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects

NCT02365766

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • IU Health Central Indiana Cancer Center Indianapolis, Indiana, United States
  • Community Regional Cancer Care Indianapolis, Indiana, United States
  • St. Vincent Hospital Indianapolis, Indiana, United States
View Trial Details

Related conditions